HomeNewsBusinessMarketsTrade Spotlight | What should you do with Glenmark Pharma, Navin Fluorine, Raymond & Birlasoft stocks?

Trade Spotlight | What should you do with Glenmark Pharma, Navin Fluorine, Raymond & Birlasoft stocks?

Here's what Mazhar Mohammad of chartviewindia.in, recommends investors should do with these stocks when the market resumes trading today.

November 24, 2021 / 12:53 IST
Story continues below Advertisement

The market rebounded with half a percent gains on November 23 after witnessing a sell-off in four consecutive sessions, driven by buying in almost all sectors with metals, pharma, and PSU bank indices being the prominent gainers.

The Nifty50 closed a tad above the 17,500 mark with 87 points gains, and the BSE Sensex gained nearly 200 points to close at 58,664, while the broader markets outpaced the benchmark indices with the Nifty Midcap 100 and Smallcap 100 indices rising 1.76 percent and 1.91 percent, respectively.

Story continues below Advertisement

Stocks that were in focus include Glenmark Pharma, which was the biggest gainer in the futures and options segment and rallied 10.11 percent to close at Rs 516.70, and Birlasoft, which was the second biggest gainer in the F&O segment, climbing 9.55 percent to Rs 500.35.

Navin Fluorine International was also in focus, rising 6.97 percent to Rs 3,516.55, and Raymond surged 16.13 percent to Rs 588.20.